Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jehonathan H Pinthus

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
European Urology|December 22, 2007
Editorial comment on: photodynamic diagnosis in urology: state-of-the-artJehonathan H Pinthus
The Journal of Urology|March 22, 2015
Uncovering the metabolic complications of androgen deprivation therapy in patients with prostate cancer--where do we take it next?Jehonathan H Pinthus
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 19, 2015
Follicle-stimulating hormone: A potential surrogate marker for androgen deprivation therapy oncological and systemic effectsJehonathan H Pinthus
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 8, 2011
ADT and the metabolic syndrome: no good deed goes unpunishedJehonathan H Pinthus
The Journal of Urology|December 27, 2021
Editorial CommentJehonathan H Pinthus
The Journal of Urology|June 15, 2018
Editorial CommentJehonathan H Pinthus
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 11, 2008
The question of repeat biopsiesJehonathan H Pinthus
The Journal of Urology|October 10, 2022
Editorial CommentBraden Millan, Jehonathan H Pinthus
The Journal of Urology|June 4, 2021
Editorial CommentJehonathan H Pinthus, Harkanwal Randhawa
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 27, 2017
Does androgen-deprivation therapy for prostate cancer increase the risk for thromboembolic disease?Jehonathan H Pinthus, Wilhelmina C Duivenvoorden
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
European Urology|December 22, 2007
Editorial comment on: photodynamic diagnosis in urology: state-of-the-artJehonathan H Pinthus
The Journal of Urology|March 22, 2015
Uncovering the metabolic complications of androgen deprivation therapy in patients with prostate cancer--where do we take it next?Jehonathan H Pinthus
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 19, 2015
Follicle-stimulating hormone: A potential surrogate marker for androgen deprivation therapy oncological and systemic effectsJehonathan H Pinthus
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 8, 2011
ADT and the metabolic syndrome: no good deed goes unpunishedJehonathan H Pinthus
The Journal of Urology|December 27, 2021
Editorial CommentJehonathan H Pinthus
The Journal of Urology|June 15, 2018
Editorial CommentJehonathan H Pinthus
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 11, 2008
The question of repeat biopsiesJehonathan H Pinthus
The Journal of Urology|October 10, 2022
Editorial CommentBraden Millan, Jehonathan H Pinthus
The Journal of Urology|June 4, 2021
Editorial CommentJehonathan H Pinthus, Harkanwal Randhawa
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 27, 2017
Does androgen-deprivation therapy for prostate cancer increase the risk for thromboembolic disease?Jehonathan H Pinthus, Wilhelmina C Duivenvoorden
Pageof 8